Cleavage and polyadenylation specificity factor subunit 1 (250-258)

Cleavage and polyadenylation specificity factor subunit 1 (250-258) is a synthetic peptide fragment corresponding to amino acids 250 through 258 of the CPSF1 protein, a central component of the eukaryotic pre-mRNA 3'-end processing machinery. As part of the larger cleavage and polyadenylation specificity factor (CPSF) complex, CPSF1 plays a pivotal role in recognizing the polyadenylation signal and mediating the endonucleolytic cleavage and polyadenylation of pre-mRNA transcripts. The 250-258 peptide region represents a defined sequence within the protein, often employed in molecular biology and biochemical studies to probe protein-protein interactions, investigate post-translational modifications, or serve as an epitope for antibody production. Its defined sequence and structural features make it a valuable tool for dissecting the mechanistic underpinnings of mRNA maturation and regulation.

Peptide mapping: Researchers utilize the 250-258 segment of CPSF1 to perform detailed peptide mapping studies, which are essential for characterizing the structural and functional domains of the full-length protein. By isolating and analyzing this specific region, scientists can determine its role within the CPSF complex, assess its involvement in binding interactions, and map critical residues necessary for the recognition of polyadenylation signals. Such mapping supports the elucidation of structure-function relationships, informing broader understanding of mRNA processing pathways.

Epitope identification: The defined sequence of the CPSF1 (250-258) peptide serves as a valuable epitope for generating and validating antibodies specific to this region of the protein. In immunological assays such as Western blotting, ELISA, or immunoprecipitation, synthetic peptides corresponding to unique regions of a target protein are commonly used to raise polyclonal or monoclonal antibodies. These antibodies, in turn, enable sensitive detection and quantification of CPSF1 in complex biological samples, facilitating studies of its expression, localization, and regulation under various experimental conditions.

Protein interaction studies: The peptide fragment encompassing residues 250-258 can be employed in in vitro binding assays to investigate protein-protein or protein-nucleic acid interactions involving CPSF1. By using this defined sequence as a probe, researchers can dissect the interaction interfaces within the CPSF complex or with other factors involved in 3'-end processing. Such studies help clarify the molecular determinants governing assembly and function of the polyadenylation machinery, providing insights into the regulation of gene expression at the post-transcriptional level.

Post-translational modification analysis: Synthetic peptides corresponding to specific regions of regulatory proteins are frequently used to study post-translational modifications such as phosphorylation, acetylation, or methylation. The CPSF1 (250-258) fragment can serve as a substrate in kinase or other modification assays, enabling the identification and characterization of modification sites within this domain. These analyses contribute to understanding how dynamic modifications influence CPSF1 function and, by extension, the efficiency and fidelity of mRNA 3'-end processing.

Peptide-based assay development: The well-defined nature of the CPSF1 (250-258) sequence makes it suitable for use in the development and optimization of biochemical assays targeting the polyadenylation pathway. For example, it can be incorporated into peptide arrays, competitive binding assays, or high-throughput screening platforms designed to identify small molecules or biologics that modulate CPSF1 activity. Such assays are instrumental in advancing research on RNA processing and in the discovery of novel modulators of gene expression.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII